| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 670313 | Null | 0.0459335986102865 | 0.11602598 |
| NSC 671170 | Null | 0.0459335986102865 | 0.52310546 |
| NSC 676772 | Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arbinopyranosyl] ester | 0.0459335986102865 | 0.13096311 |
| NSC 676779 | Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop | 0.0459335986102865 | 0.058442263 |
| NSC 677174 | Null | 0.0459335986102865 | 0.069395079 |
| NSC 681239 | Bortezomib | 0.0459335986102865 | 0.27029091 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.0459335986102865 | 0.32858127 |
| NSC 682764 | Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- | 0.0459335986102865 | -0.053251556 |
| NSC 694220 | Null | 0.0459335986102865 | -0.18029425 |
| NSC 703855 | Null | 0.0459335986102865 | 0.20570865 |